World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
163
Citations
140168
World Ranking
670
National Ranking
386

Overview

Richard A. Larson is affiliated with the University of Chicago in the United States. Their academic work is concentrated primarily in the field of Medicine, with a particular emphasis on hematology, genetics, public health, oncology, and molecular biology.

Their research covers several subfields, including:

  • Hematology
  • Genetics
  • Public Health, Environmental and Occupational Health
  • Oncology
  • Molecular Biology

Richard A. Larson has contributed extensively to topics within leukemia research and treatment. Main topics of their work include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation

The scientist has published in prominent venues frequently associated with hematology and oncology. The leading publication venues include:

  • Blood
  • Blood Advances
  • Leukemia
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology

Some recent notable papers authored by or connected with Richard A. Larson include:

  • Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN, 2022, published in Blood
  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data, 2022, published in Blood
  • European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia, 2020, published in Leukemia
  • Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis, 2021, published in Leukemia
  • Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin, 2021, published in Blood

Frequent collaborators in their research include:

  • Wendy Stock
  • Richard M. Stone
  • Olatoyosi Odenike
  • Anand Patel
  • Jorge E. Cortés

The focus of their work spans from basic science in molecular biology to clinical implications in leukemia treatment and public health, indicating a broad and interdisciplinary approach to hematologic malignancies and therapies.

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

    Stephen G. O'Brien;François Guilhot;Richard A. Larson;Insa Gathmann

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • The antioxidants of higher plants

    Richard A. Larson

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

    Lewis R. Silverman;Erin P. Demakos;Bercedis L. Peterson;Alice B. Kornblith

  • Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

    Giuseppe Saglio;Dong-Wook Kim;Surapol Issaragrisil;Gabriel Etienne

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus

  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

    Kanti R. Rai;Bercedis L. Peterson;Frederick R. Appelbaum;Jonathan Kolitz

  • FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6-Methyladenosine RNA Demethylase

    Zejuan Li;Hengyou Weng;Hengyou Weng;Rui Su;Xiaocheng Weng;Xiaocheng Weng

  • Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

    Max S. Topp;Nicola Gökbuget;Anthony S. Stein;Gerhard Zugmaier

  • European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    Andreas Hochhaus;Michele Baccarani;Richard T. Silver;Charles A. Schiffer

  • Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

    Eric L. Sievers;Richard A. Larson;Edward A. Stadtmauer;Elihu Estey

  • Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

    Andreas Hochhaus;Richard A. Larson;François Guilhot;Jerald P. Radich

Frequent Co-Authors

Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
Bayard L. Powell
Bayard L. Powell Wake Forest University
Richard Stone
Richard Stone Harvard University
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Lucy A. Godley
Lucy A. Godley University of Chicago
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
James W. Vardiman
James W. Vardiman University of Chicago
Jonathan E. Kolitz
Jonathan E. Kolitz Hofstra University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a range of related online degrees and opportunities in healthcare. Many students start their journey in the field through nursing schools that don't require teas or hesi entrance exams. These programs can make nursing more accessible without the need for standardized test scores.

For those interested in the operational side of healthcare, a health care administration degree online provides a pathway toward management and leadership roles in hospitals and clinics. These programs are designed for flexibility, allowing students to balance study with work commitments.

If you are an RN seeking further career advancement, consider rn to fnp programs. These bridge programs help registered nurses transition into advanced nurse practitioner roles, expanding their scope of practice and earning potential.

Nutrition is another vital component of healthcare. The best online nutrition programs offer specialized education in dietetics and wellness, preparing graduates for careers in clinical nutrition, public health, and food science.

Best Scientists Citing Richard A. Larson

Trending Scientists

Recently Published Articles